Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Circulating tumor cells exhibit metastatic tropism and reveal brain metastasis drivers.

Klotz R, Thomas A, Teng T, Han SM, Iriondo O, Li L, Restrepo-Vassalli S, Wang A, Izadian N, MacKay M, Moon BS, Liu KJ, Ganesan SK, Lee G, Kang DS, Walmsley CS, Pinto CJ, Press MF, Lu W, Lu J, Juric D, Bardia A, Hicks J, Salhia B, Attenello FJ, Smith AD, Yu M.

Cancer Discov. 2019 Oct 10. pii: CD-19-0384. doi: 10.1158/2159-8290.CD-19-0384. [Epub ahead of print]

PMID:
31601552
2.

Pathology Services in Nigeria: Cross-Sectional Survey Results From Three Cancer Consortia.

Ntiamoah P, Monu NR, Abdulkareem FB, Adeniji KA, Obafunwa JO, Komolafe AO, Yates C, Kaninjing E, Carpten JD, Salhia B, Odedina FT, Edelweiss M, Kingham TP, Alatise OI.

J Glob Oncol. 2019 Sep;5:1-9. doi: 10.1200/JGO.19.00138.

3.

Patient-derived xenografts of central nervous system metastasis reveal expansion of aggressive minor clones.

Tew BY, Legendre C, Schroeder MA, Triche T, Gooden GC, Huang Y, Butry L, Ma DJ, Johnson K, Martinez RA, Pierobon M, Petricoin EF, O'Shaughnessy J, Osborne C, Tapia C, Buckley DN, Glen J, Bernstein M, Sarkaria JN, Toms SA, Salhia B.

Neuro Oncol. 2019 Aug 21. pii: noz137. doi: 10.1093/neuonc/noz137. [Epub ahead of print]

PMID:
31433055
4.

AMPK variant, a candidate of novel predictor for chemotherapy in metastatic colorectal cancer: A meta-analysis using TRIBE, MAVERICC and FIRE3.

Tokunaga R, Cao S, Naseem M, Battaglin F, Lo JH, Arai H, Loupakis F, Stintzing S, Puccini A, Berger MD, Soni S, Zhang W, Mancao C, Salhia B, Mumenthaler SM, Weisenberger DJ, Liang G, Cremolini C, Heinemann V, Falcone A, Millstein J, Lenz HJ.

Int J Cancer. 2019 Oct 15;145(8):2082-2090. doi: 10.1002/ijc.32261. Epub 2019 Mar 26.

PMID:
30856283
5.

Impact of polymorphisms within genes involved in regulating DNA methylation in patients with metastatic colorectal cancer enrolled in three independent, randomised, open-label clinical trials: a meta-analysis from TRIBE, MAVERICC and FIRE-3.

Puccini A, Loupakis F, Stintzing S, Cao S, Battaglin F, Togunaka R, Naseem M, Berger MD, Soni S, Zhang W, Mancao C, Salhia B, Mumenthaler SM, Weisenberger DJ, Liang G, Cremolini C, Heinemann V, Falcone A, Millstein J, Lenz HJ.

Eur J Cancer. 2019 Apr;111:138-147. doi: 10.1016/j.ejca.2019.01.105. Epub 2019 Mar 7.

PMID:
30852420
6.

Publisher Correction: The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions.

Bolouri H, Farrar JE, Triche T Jr, Ries RE, Lim EL, Alonzo TA, Ma Y, Moore R, Mungall AJ, Marra MA, Zhang J, Ma X, Liu Y, Liu Y, Auvil JMG, Davidsen TM, Gesuwan P, Hermida LC, Salhia B, Capone S, Ramsingh G, Zwaan CM, Noort S, Piccolo SR, Kolb EA, Gamis AS, Smith MA, Gerhard DS, Meshinchi S.

Nat Med. 2019 Mar;25(3):530. doi: 10.1038/s41591-019-0369-7.

PMID:
30705421
7.

Isolation and characterization of patient-derived CNS metastasis-associated stromal cell lines.

Tew BY, Legendre C, Gooden GC, Johnson KN, Martinez RA, Kiefer J, Bernstein M, Glen J, Butry L, Hinek A, Toms SA, Salhia B.

Oncogene. 2019 May;38(21):4002-4014. doi: 10.1038/s41388-019-0680-2. Epub 2019 Jan 30.

8.

Lack of APC somatic mutation is associated with early-onset colorectal cancer in African Americans.

Xicola RM, Manojlovic Z, Augustus GJ, Kupfer SS, Emmadi R, Alagiozian-Angelova V, Triche T Jr, Salhia B, Carpten J, Llor X, Ellis NA.

Carcinogenesis. 2018 Dec 13;39(11):1331-1341. doi: 10.1093/carcin/bgy122.

PMID:
30239619
9.

Comprehensive Genomic Profiling of Hodgkin Lymphoma Reveals Recurrently Mutated Genes and Increased Mutation Burden.

Liang WS, Vergilio JA, Salhia B, Huang HJ, Oki Y, Garrido-Laguna I, Park H, Westin JR, Meric-Bernstam F, Fabrizio D, Miller VA, Stephens PJ, Fanale MA, Ross JS, Janku F.

Oncologist. 2019 Feb;24(2):219-228. doi: 10.1634/theoncologist.2018-0058. Epub 2018 Aug 14.

10.

Erratum: The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions.

Bolouri H, Farrar JE, Triche T Jr, Ries RE, Lim EL, Alonzo TA, Ma Y, Moore R, Mungall AJ, Marra MA, Zhang J, Ma X, Liu Y, Liu Y, Auvil JMG, Davidsen TM, Gesuwan P, Hermida LC, Salhia B, Capone S, Ramsingh G, Zwaan CM, Noort S, Piccolo SR, Kolb EA, Gamis AS, Smith MA, Gerhard DS, Meshinchi S.

Nat Med. 2018 Apr 10;24(4):526. doi: 10.1038/nm0418-526b.

PMID:
29634680
11.

A phase 1 study of azacitidine combined with chemotherapy in childhood leukemia: a report from the TACL consortium.

Sun W, Triche T Jr, Malvar J, Gaynon P, Sposto R, Yang X, Bittencourt H, Place AE, Messinger Y, Fraser C, Dalla-Pozza L, Salhia B, Jones P, Wayne AS, Gore L, Cooper TM, Liang G.

Blood. 2018 Mar 8;131(10):1145-1148. doi: 10.1182/blood-2017-09-803809. Epub 2018 Jan 16. No abstract available.

12.

Immunophenotypic profile of tumor buds in breast cancer.

Laedrach C, Salhia B, Cihoric N, Zlobec I, Tapia C.

Pathol Res Pract. 2018 Jan;214(1):25-29. doi: 10.1016/j.prp.2017.11.023. Epub 2017 Dec 5.

13.

The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions.

Bolouri H, Farrar JE, Triche T Jr, Ries RE, Lim EL, Alonzo TA, Ma Y, Moore R, Mungall AJ, Marra MA, Zhang J, Ma X, Liu Y, Liu Y, Auvil JMG, Davidsen TM, Gesuwan P, Hermida LC, Salhia B, Capone S, Ramsingh G, Zwaan CM, Noort S, Piccolo SR, Kolb EA, Gamis AS, Smith MA, Gerhard DS, Meshinchi S.

Nat Med. 2018 Jan;24(1):103-112. doi: 10.1038/nm.4439. Epub 2017 Dec 11. Erratum in: Nat Med. 2018 Apr 10;24(4):526. Nat Med. 2019 Mar;25(3):530.

14.

A multicenter, randomized study of decitabine as epigenetic priming with induction chemotherapy in children with AML.

Gore L, Triche TJ Jr, Farrar JE, Wai D, Legendre C, Gooden GC, Liang WS, Carpten J, Lee D, Alvaro F, Macy ME, Arndt C, Barnette P, Cooper T, Martin L, Narendran A, Pollard J, Meshinchi S, Boklan J, Arceci RJ, Salhia B.

Clin Epigenetics. 2017 Oct 5;9:108. doi: 10.1186/s13148-017-0411-x. eCollection 2017.

15.

Mitochondrial Genomic Backgrounds Affect Nuclear DNA Methylation and Gene Expression.

Vivian CJ, Brinker AE, Graw S, Koestler DC, Legendre C, Gooden GC, Salhia B, Welch DR.

Cancer Res. 2017 Nov 15;77(22):6202-6214. doi: 10.1158/0008-5472.CAN-17-1473. Epub 2017 Jun 29.

16.

Integrated genomic analysis of survival outliers in glioblastoma.

Peng S, Dhruv H, Armstrong B, Salhia B, Legendre C, Kiefer J, Parks J, Virk S, Sloan AE, Ostrom QT, Barnholtz-Sloan JS, Tran NL, Berens ME.

Neuro Oncol. 2017 Jun 1;19(6):833-844. doi: 10.1093/neuonc/now269. Erratum in: Neuro Oncol. 2017 Apr 1;19(4):601.

17.

Pathway Implications of Aberrant Global Methylation in Adrenocortical Cancer.

Legendre CR, Demeure MJ, Whitsett TG, Gooden GC, Bussey KJ, Jung S, Waibhav T, Kim S, Salhia B.

PLoS One. 2016 Mar 10;11(3):e0150629. doi: 10.1371/journal.pone.0150629. eCollection 2016.

18.

Androgen receptor status is highly conserved during tumor progression of breast cancer.

Grogg A, Trippel M, Pfaltz K, Lädrach C, Droeser RA, Cihoric N, Salhia B, Zweifel M, Tapia C.

BMC Cancer. 2015 Nov 9;15:872. doi: 10.1186/s12885-015-1897-2.

19.

Whole-genome bisulfite sequencing of cell-free DNA identifies signature associated with metastatic breast cancer.

Legendre C, Gooden GC, Johnson K, Martinez RA, Liang WS, Salhia B.

Clin Epigenetics. 2015 Sep 16;7:100. doi: 10.1186/s13148-015-0135-8. eCollection 2015.

20.

High tumor budding stratifies breast cancer with metastatic properties.

Salhia B, Trippel M, Pfaltz K, Cihoric N, Grogg A, Lädrach C, Zlobec I, Tapia C.

Breast Cancer Res Treat. 2015 Apr;150(2):363-71. doi: 10.1007/s10549-015-3333-3. Epub 2015 Mar 17.

21.

Breast cancer in adolescent and young adult women.

Gewefel H, Salhia B.

Clin Breast Cancer. 2014 Dec;14(6):390-5. doi: 10.1016/j.clbc.2014.06.002. Epub 2014 Jun 23. Review.

PMID:
25034440
22.

Molecular biology of brain metastasis.

Svokos KA, Salhia B, Toms SA.

Int J Mol Sci. 2014 May 28;15(6):9519-30. doi: 10.3390/ijms15069519. Review.

23.

Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4.

Ramos P, Karnezis AN, Craig DW, Sekulic A, Russell ML, Hendricks WP, Corneveaux JJ, Barrett MT, Shumansky K, Yang Y, Shah SP, Prentice LM, Marra MA, Kiefer J, Zismann VL, McEachron TA, Salhia B, Prat J, D'Angelo E, Clarke BA, Pressey JG, Farley JH, Anthony SP, Roden RB, Cunliffe HE, Huntsman DG, Trent JM.

Nat Genet. 2014 May;46(5):427-9. doi: 10.1038/ng.2928. Epub 2014 Mar 23.

24.

Current approaches to the treatment of metastatic brain tumours.

Owonikoko TK, Arbiser J, Zelnak A, Shu HK, Shim H, Robin AM, Kalkanis SN, Whitsett TG, Salhia B, Tran NL, Ryken T, Moore MK, Egan KM, Olson JJ.

Nat Rev Clin Oncol. 2014 Apr;11(4):203-22. doi: 10.1038/nrclinonc.2014.25. Epub 2014 Feb 25. Review.

25.

Integrated genomic and epigenomic analysis of breast cancer brain metastasis.

Salhia B, Kiefer J, Ross JT, Metapally R, Martinez RA, Johnson KN, DiPerna DM, Paquette KM, Jung S, Nasser S, Wallstrom G, Tembe W, Baker A, Carpten J, Resau J, Ryken T, Sibenaller Z, Petricoin EF, Liotta LA, Ramanathan RK, Berens ME, Tran NL.

PLoS One. 2014 Jan 29;9(1):e85448. doi: 10.1371/journal.pone.0085448. eCollection 2014.

26.

In vitro-differentiated neural cell cultures progress towards donor-identical brain tissue.

Hjelm BE, Salhia B, Kurdoglu A, Szelinger S, Reiman RA, Sue LI, Beach TG, Huentelman MJ, Craig DW.

Hum Mol Genet. 2013 Sep 1;22(17):3534-46. doi: 10.1093/hmg/ddt208. Epub 2013 May 10.

27.

DNA methylation in multiple myeloma is weakly associated with gene transcription.

Jung S, Kim S, Gale M, Cherni I, Fonseca R, Carpten J, Salhia B.

PLoS One. 2012;7(12):e52626. doi: 10.1371/journal.pone.0052626. Epub 2012 Dec 20.

28.

Genome and transcriptome sequencing in prospective metastatic triple-negative breast cancer uncovers therapeutic vulnerabilities.

Craig DW, O'Shaughnessy JA, Kiefer JA, Aldrich J, Sinari S, Moses TM, Wong S, Dinh J, Christoforides A, Blum JL, Aitelli CL, Osborne CR, Izatt T, Kurdoglu A, Baker A, Koeman J, Barbacioru C, Sakarya O, De La Vega FM, Siddiqui A, Hoang L, Billings PR, Salhia B, Tolcher AW, Trent JM, Mousses S, Von Hoff D, Carpten JD.

Mol Cancer Ther. 2013 Jan;12(1):104-16. doi: 10.1158/1535-7163.MCT-12-0781. Epub 2012 Nov 19.

29.

Differential effects of AKT1(p.E17K) expression on human mammary luminal epithelial and myoepithelial cells.

Salhia B, Van Cott C, Tegeler T, Polpitiya A, Duquette RA, Gale M, Hostteter G, Petritis K, Carpten J.

Hum Mutat. 2012 Aug;33(8):1216-27. doi: 10.1002/humu.22100. Epub 2012 May 11.

PMID:
22505016
30.

Molecular subtype analysis determines the association of advanced breast cancer in Egypt with favorable biology.

Salhia B, Tapia C, Ishak EA, Gaber S, Berghuis B, Hussain KH, DuQuette RA, Resau J, Carpten J.

BMC Womens Health. 2011 Sep 30;11:44. doi: 10.1186/1472-6874-11-44.

31.

DNA methylation analysis determines the high frequency of genic hypomethylation and low frequency of hypermethylation events in plasma cell tumors.

Salhia B, Baker A, Ahmann G, Auclair D, Fonseca R, Carpten J.

Cancer Res. 2010 Sep 1;70(17):6934-44. doi: 10.1158/0008-5472.CAN-10-0282. Epub 2010 Aug 24.

32.
33.

The guanine nucleotide exchange factors trio, Ect2, and Vav3 mediate the invasive behavior of glioblastoma.

Salhia B, Tran NL, Chan A, Wolf A, Nakada M, Rutka F, Ennis M, McDonough WS, Berens ME, Symons M, Rutka JT.

Am J Pathol. 2008 Dec;173(6):1828-38. doi: 10.2353/ajpath.2008.080043. Epub 2008 Nov 13.

34.

The role of fascin in the migration and invasiveness of malignant glioma cells.

Hwang JH, Smith CA, Salhia B, Rutka JT.

Neoplasia. 2008 Feb;10(2):149-59.

35.

Role of myosin II activity and the regulation of myosin light chain phosphorylation in astrocytomas.

Salhia B, Hwang JH, Smith CA, Nakada M, Rutka F, Symons M, Rutka JT.

Cell Motil Cytoskeleton. 2008 Jan;65(1):12-24.

PMID:
17896341
36.

Current concepts in the molecular genetics of pediatric brain tumors: implications for emerging therapies.

Tamber MS, Bansal K, Liang ML, Mainprize TG, Salhia B, Northcott P, Taylor M, Rutka JT.

Childs Nerv Syst. 2006 Nov;22(11):1379-94. Epub 2006 Sep 2. Review.

PMID:
16951964
37.

Molecular pathways triggering glioma cell invasion.

Salhia B, Tran NL, Symons M, Winkles JA, Rutka JT, Berens ME.

Expert Rev Mol Diagn. 2006 Jul;6(4):613-26. Review.

PMID:
16824034
38.

Inhibition of Rho-kinase affects astrocytoma morphology, motility, and invasion through activation of Rac1.

Salhia B, Rutten F, Nakada M, Beaudry C, Berens M, Kwan A, Rutka JT.

Cancer Res. 2005 Oct 1;65(19):8792-800.

39.

Analysis of mammalian septin expression in human malignant brain tumors.

Kim DS, Hubbard SL, Peraud A, Salhia B, Sakai K, Rutka JT.

Neoplasia. 2004 Mar-Apr;6(2):168-78.

40.

Imaging of murine brain tumors using a 1.5 Tesla clinical MRI system.

van Furth WR, Laughlin S, Taylor MD, Salhia B, Mainprize T, Henkelman M, Cusimano MD, Ackerley C, Rutka JT.

Can J Neurol Sci. 2003 Nov;30(4):326-32.

PMID:
14672264
41.

The treatment of malignant meningioma with verotoxin.

Salhia B, Rutka JT, Lingwood C, Nutikka A, Van Furth WR.

Neoplasia. 2002 Jul-Aug;4(4):304-11.

42.

Evaluation of proliferative index and cell cycle protein expression in choroid plexus tumors in children.

Carlotti CG Jr, Salhia B, Weitzman S, Greenberg M, Dirks PB, Mason W, Becker LE, Rutka JT.

Acta Neuropathol. 2002 Jan;103(1):1-10.

PMID:
11837741
43.

Hyaluronate receptors mediating glioma cell migration and proliferation.

Akiyama Y, Jung S, Salhia B, Lee S, Hubbard S, Taylor M, Mainprize T, Akaishi K, van Furth W, Rutka JT.

J Neurooncol. 2001 Jun;53(2):115-27.

PMID:
11716065
44.
45.

Expression of vascular endothelial growth factor by reactive astrocytes and associated neoangiogenesis.

Salhia B, Angelov L, Roncari L, Wu X, Shannon P, Guha A.

Brain Res. 2000 Nov 10;883(1):87-97.

PMID:
11063991
46.
47.

Elective neurosurgical office consultations: how well are patients informed?

Bampoe J, Salhia B, Micallef J, Glen J, Bernstein M.

Can J Public Health. 1998 Jul-Aug;89(4):280-3.

PMID:
9735526

Supplemental Content

Loading ...
Support Center